IPO Issue Details
Issue Price / Price Band₹43 per share (Fixed Price)
Face Value₹10 Per Share
Lot Size3,000 Shares per Lot
Total Issue Size37,44,000 shares (aggregating up to ₹16.10 Cr)
Issue TypeFixed Price IPO
Sale Type / CategoryFresh Capital
Exchange / PlatformNSE SME
IPO TypeSME
Subscription OpenFri, 08 Aug 2025
Subscription CloseTue, 12 Aug 2025
Anchor AllotmentThu, 07 Aug 2025
Basis of AllotmentWed, 13 Aug 2025
Initiation of RefundsThu, 14 Aug 2025
Credit of Shares to DematThu, 14 Aug 2025
Listing DateMon, 18 Aug 2025
UPI Mandate Deadline2025-08-12
Application & Investment Details
Retail — Min (2 Lots)₹2,58,000 — 6000 shares
Retail — Max (13 Lots)₹1,677,000 (13 Lots)
HNI — Min (3 Lots)3,87,000 — 9000 shares
EPS (Pre-IPO)₹3.96
EPS (Post-IPO)₹2.92
P/E Ratio (Pre-IPO)10.86x
P/E Ratio (Post-IPO)14.74x
Net Offer to Public35,55,000 shares (aggregating up to ₹15.29 Cr)
Reserved for Market Maker1,89,000 shares (aggregating up to ₹0.8127 Cr)
Pre-IPO Promoter Holding1,04,65,546 shares
Post-IPO Promoter Holding1,42,09,546 shares
About Medistep Healthcare Ltd.
Incorporated in June 2023, Medistep Healthcare Limited is a pharmaceutical company producing sanitary pads, energy powder, and various pharmaceutical, nutraceutical, intimate, and surgical products. They are committed to quality and seek to expand their product line as a public, non-government company.The product includes the followings:-Sanitary Pads: Medistep produces high-quality sanitary pads, addressing essential feminine hygiene needs.Energy Powder: The company manufactures energy supplements designed to revitalize and invigorate consumers.Pharmaceutical Products: Medistep engages in the trading of various pharmaceutical items, ensuring accessibility to essential medications.Nutraceutical Products: They offer products that blend nutrition and pharmaceuticals, promoting overall health and wellness.Intimate Care and Hygiene Products: The company provides personal hygiene and intimate care products.Surgical Products: Medistep supplies surgical items and supports medical professionals with necessary tools and equipment.As of December 30, 2024, Medistep reported annualized revenues of ₹45.00 crore and a Profit After Tax (PAT) of ₹4.08 crore.As of December 28, 2024, the company has nine employees on payroll. Labour needs depend on daily-paid labourers, and none are on contract.Competitive Strength:Experienced Promoters and Management Team.Maximize resources for quality supply and cost savings through economies of scale.Offers various products, including trading in pharmaceutical and healthcare items, manufacturing DRYSTEP sanitary pads, and VITASTEP Z energy powders.
Objects of the Issue
Medistep Healthcare Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
1
1 Funding of capital expenditure towards purchase of plant and machineries for expansion at the existing manufacturing facility
0.51
2
2 Working Capital requirements
12.34
3
3 General Corporate Purpose
1.64
Shareholding & Lock-in
Pre-IPO Promoter Holding
1,04,65,546 shares
Post-IPO Promoter Holding
1,42,09,546 shares